Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Moye, Jack"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-3 z 3
    Tytuł:
    Adolescent and young adult research across the HIV prevention and care continua: an international programme analysis and targeted review.
    Autorzy:
    Calabrese S; Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
    Perkins M; Office of Portfolio Analysis, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, National Institutes of Health, Bethesda, Maryland, USA.
    Lee S; Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
    Allison S; Developmental and Clinical Neuroscience of HIV Prevention and Treatment Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA.
    Brown G; Office of AIDS Research, National Institutes of Health, Bethesda, Maryland, USA.; Medical Affairs, HIV Prevention, Gilead Sciences, Inc., New York City, New York, USA.
    Jean-Philippe P; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
    Chakhtoura N; Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
    Moye J; Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
    Kapogiannis BG; Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
    Pokaż więcej
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2023 Mar; Vol. 26 (3), pp. e26065.
    Typ publikacji:
    Systematic Review; Journal Article; Review
    MeSH Terms:
    HIV Infections*/drug therapy
    HIV Infections*/prevention & control
    Sexual and Gender Minorities*
    Male ; Humans ; Young Adult ; Adolescent ; HIV ; Homosexuality, Male ; Continuity of Patient Care
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis.
    Autorzy:
    Krogstad P; Departments of Pediatrics and Molecular and Medical Pharmacology, David Geffen School of Medicine at Los Angeles, Los Angeles, California, USA.
    Samson P; Statistical and Data Management Center, Frontier Science Foundation/Harvard T.H. Chan School of Public Health Boston, Massachusetts, USA.
    Acosta EP; Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
    Moye J; Maternal and Pediatric Infectious Disease Branch, Division of Extramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, USA.
    Townley E; Columbus Technologies and Services, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
    Bradford S; FHI360, Durham, North Carolina, USA.
    Brown E; FHI360, Durham, North Carolina, USA.
    Denson K; Frontier Science Foundation, Inc, Amherst, New York, USA.
    Graham B; Frontier Science Foundation, Inc, Amherst, New York, USA.
    Hovind L; Frontier Science Foundation, Inc, Amherst, New York, USA.
    Sise T; Columbus Technologies and Services, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
    Teppler H; Global Clinical Development - Infectious Diseases, Merck & Co, Inc, Kenilworth, New Jersey, USA.
    Mathiba SR; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
    Fairlie L; Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
    Winckler JL; Desmond Tutu TB Centre, Department of Paediatrics, Stellenbosch University, Cape Town South Africa.
    Slade G; Department of Paediatrics and Child Health, Family Clinical Research Unit, Stellenbosch University, Cape Town, South Africa.
    Meyers T; Department of Paediatrics, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
    Pokaż więcej
    Corporate Authors:
    International Maternal Pediatric Adolescent AIDS Clinical Trials Network P1101 Team
    Źródło:
    Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2021 Mar 26; Vol. 10 (2), pp. 201-204.
    Typ publikacji:
    Clinical Trial; Journal Article
    MeSH Terms:
    Anti-HIV Agents*/therapeutic use
    HIV Infections*/drug therapy
    Tuberculosis*/complications
    Tuberculosis*/drug therapy
    Child ; HIV ; Humans ; Raltegravir Potassium/adverse effects ; Rifampin/adverse effects
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Combined evaluation of sexually transmitted infections in HIV-infected pregnant women and infant HIV transmission.
    Autorzy:
    Adachi K; David Geffen UCLA School of Medicine, Los Angeles, CA, United States of America.
    Xu J; Westat, Rockville, MD, United States of America.
    Yeganeh N; David Geffen UCLA School of Medicine, Los Angeles, CA, United States of America.
    Camarca M; Westat, Rockville, MD, United States of America.
    Morgado MG; Fundacao Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
    Watts DH; Office of the Global AIDS Coordinator, U.S. Department of State, Washington D.C., United States of America.
    Mofenson LM; Elizabeth Glaser Pediatric AIDS Foundation, Washington D.C., United States of America.
    Veloso VG; Fundacao Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
    Pilotto JH; Hospital Geral de Nova Iguaçu, Nova Iguaçu, RJ, Brazil.
    Joao E; Hospital Federal dos Servidores do Estado, Rio de Janeiro, RJ, Brazil.
    Gray G; SAMRC and Perinatal HIV Research Unit, University of Witwatersrand, Johannesburg, South Africa.
    Theron G; Stellenbosch University/Tygerberg Hospital, Cape Town, South Africa.
    Santos B; Hospital Conceicao, Porto Alegre, RS, Brazil.
    Fonseca R; Hospital Femina, Porto Alegre, RS, Brazil.
    Kreitchmann R; Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, RS, Brazil.
    Pinto J; Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
    Mussi-Pinhata MM; Ribeirão Preto Medical School, University of São Paulo, São Paulo, SP, Brazil.
    Ceriotto M; Foundation for Maternal and Infant Health (FUNDASAMIN), Buenos Aires, Argentina.
    Machado DM; Escola Paulista de Medicina-Universidade Federal de São Paulo, São Paulo, SP, Brazil.
    Bryson YJ; David Geffen UCLA School of Medicine, Los Angeles, CA, United States of America.
    Grinsztejn B; Fundacao Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
    Moye J; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States of America.
    Klausner JD; David Geffen UCLA School of Medicine, Los Angeles, CA, United States of America.; UCLA Fielding School of Public Health, Los Angeles, CA, United States of America.
    Bristow CC; UCSD School of Medicine, La Jolla, CA, United States of America.
    Dickover R; UC Davis School of Medicine, Davis, CA, United States of America.
    Mirochnick M; Boston University School of Medicine, Boston, MA, United States of America.
    Nielsen-Saines K; David Geffen UCLA School of Medicine, Los Angeles, CA, United States of America.
    Pokaż więcej
    Corporate Authors:
    NICHD HPTN 040 Study Team
    Źródło:
    PloS one [PLoS One] 2018 Jan 05; Vol. 13 (1), pp. e0189851. Date of Electronic Publication: 2018 Jan 05 (Print Publication: 2018).
    Typ publikacji:
    Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Infectious Disease Transmission, Vertical*
    Pregnancy Complications, Infectious*
    HIV Infections/*complications
    HIV Infections/*transmission
    Sexually Transmitted Diseases/*complications
    Adolescent ; Adult ; Chlamydia Infections/complications ; Chlamydia trachomatis ; Cross-Sectional Studies ; Female ; Gonorrhea/complications ; Humans ; Infant ; Infant, Newborn ; Middle Aged ; Pregnancy ; Retrospective Studies ; Risk Factors ; Syphilis/complications ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-3 z 3

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies